Final Glance: Biotechnology companies
AP - Mon May 05, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Midday Glance: Biotechnology companies
AP - Mon May 05, 12:22PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
Early Glance: Biotechnology companies
AP - Mon May 05, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Is Merrimack Pharmaceuticals Worth More Than $700 Million?
Todd Campbell, The Motley Fool - Motley Fool - Mon May 05, 8:30AM CDT
When patients are diagnosed with diseases like pancreatic cancer where survival is measured in months, not years, any advance is an important one. That's why oncologists and patients are watching Merrimack Pharmaceuticals . Merrimack just...
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene
PR Newswire - Mon May 05, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co. Inc. (NYSE: MRK), WellPoint Inc. (NYSE: WLP), UnitedHealth Group Inc. (NYSE: UNH), Forest Laboratories Inc. (NYSE: FRX) and Celgene Corporation (NASDAQ: CELG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2020-100free.
1 Biotech's Earnings the Market Got Completely Wrong
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun May 04, 2:03PM CDT
In this segment from Market Checkup , Motley Fool health-care analysts David Williamson and Michael Douglass look at the recent earnings report from biotech company Celgene , to sift out the vital numbers that investors need to know. The guys...
Biotech Sector Performance in April: Gilead Sciences Rising
at The Street - Fri May 02, 8:49AM CDT
The biotech sector was down again, but there's some hopeful signs of a recovery.
New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent
PR Newswire - Fri May 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Celgene Corporation (NASDAQ: CELG), HCA Holdings Inc. (NYSE: HCA), Thermo Fisher Scientific Inc. (NYSE: TMO), Cubist Pharmaceuticals Inc. (NASDAQ: CBST) and Agilent Technologies Inc. (NYSE: A). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1941-100free.
Health Care Stocks Still Healthy Despite Higher Hedging Costs
at The Street - Fri May 02, 5:30AM CDT
Health care is still outperforming the overall indices -- mergers and stellar sales figures and all. Can it be sustained?
Up 50%: Merrimack Pharmaceuticals' Groundbreaking News
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Thu May 01, 5:30PM CDT
Shares in Merrimack Pharmaceuticals (NASDAQ: MACK) gained over 50% today on great news regarding a phase 3 trial for its MM-398 drug for pancreatic cancer. In combination with 5-flouroacil and leucovorin, MM-398 generated a 1.9 month lift in...
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver
PR Newswire - Thu May 01, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for KO, BIDU, URBN, CELG, and TSL.
Biotech Stock Roundup: Gilead's Sovaldi Shines, Biogen & Alexion Up Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 30, 9:55AM CDT
Gilead's (GILD) Sovaldi remained in the limelight with sales blowing past expectations.